OKUR · Forms 3, 4, 5
Insider trades at OnKure Therapeutics, Inc.
2 insiders sold $1K of OnKure Therapeutics, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for OnKure Therapeutics, Inc. (OKUR) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nicholas A Saccomano | President and CEO | Sell | 87 | $2.97 | $259 | Form 4 | |
| Jason A. Leverone | Chief Financial Officer | Sell | 302 | $2.97 | $898 | Form 4 | |
| Edward T Mathers | Director | Options or other derivatives | Form 4 | ||||
| Liam Ratcliffe | Director | Options or other derivatives | Form 4 | ||||
| Andrew John Phillips | Director | Options or other derivatives | Form 4 | ||||
| Isaac Manke | Director | Options or other derivatives | Form 4 | ||||
| Valerie Malyvanh Jansen | Director | Options or other derivatives | Form 4 | ||||
| Michael G Grey | Director | Options or other derivatives | Form 4 | ||||
| R Michael Carruthers | Director | Options or other derivatives | Form 4 | ||||
| Nicholas A Saccomano | President and CEO | Options or other derivatives | Form 4 | ||||
| Jason A. Leverone | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Dylan Hartley | Chief Scientific Officer | Options or other derivatives | Form 4 | ||||
| Samuel Agresta | Chief Medical Officer | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.